Mirae Asset Global Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ACM
WHG
Mirae Asset Global Investments's BSX.PRA Position: Q3 2022 in Review
Mirae Asset Global Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q3 2022, closing a stake of 144,446 shares — an estimated $14.7M sold.
Mirae Asset Global Investments first reported a position in BSX.PRA in Q4 2021 and held it in 3 quarters. The position peaked at $17.8M in Q4 2021. 54 funds tracked by Wall St. Rank hold BSX.PRA as of Q3 2022.
- Mirae Asset Global Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q3 2022 after selling out during the quarter.
- Mirae Asset Global Investments sold 144,446 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q3 2022, an estimated $14.7M.
- Mirae Asset Global Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 3 quarters.
- Mirae Asset Global Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $17.8M in Q4 2021.
- 54 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q3 2022.
Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.